Development of a humanized mouse model of graft-versus-host disease to assess human regulatory T cell function
IntroductionRegulatory T cells (Treg)-based therapies are increasingly used for treating autoimmune or graft-versus-host (GVHD) disease. Given their low frequency, several approaches aimed at amplifying them or at increasing their immunosuppressive act…